Staar Surgical (STAA) Income from Continuing Operations (2010 - 2026)
Staar Surgical's (STAA) quarterly Income from Continuing Operations came in at $8.1 million in Q3 2026, up 147.93% on a YoY basis from $3.3 million in Q3 2025, and up 54.78% quarter-over-quarter from $5.2 million in Q2 2026.
Analysis
Staar Surgical (STAA) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has reported Income from Continuing Operations for 17 consecutive years, with $8.1 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Income from Continuing Operations rose 147.93% year-over-year to $8.1 million; the trailing twelve-month figure through Jul 2026 stood at $19.3 million (up 113.88% YoY), and the FY2026 full-year result was -$65.0 million, down 1.52% from the prior year.
- Income from Continuing Operations rose to $8.1 million in Q3 2026 per STAA's latest filing, from $5.2 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $54.1 million in Q4 2023 and bottomed at -$78.0 million in Q4 2024.
- Historically, Income from Continuing Operations has averaged $741555.6 across 5 years, with a median of $6.7 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations tumbled 1523.57% in 2025, then soared 147.93% in 2026.
- Over 5 years, Income from Continuing Operations stood at $28.4 million in 2022, then surged by 90.31% to $54.1 million in 2023, then slumped by 244.12% to -$78.0 million in 2024, then soared by 111.38% to $8.9 million in 2025, then slipped by 9.3% to $8.1 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered $8.1 million, $5.2 million, and -$2.8 million for Q3 2026, Q2 2026, and Q1 2026 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Staar Surgical | 1.18 Bn | 1.00 Bn | 69.73 Mn | 8.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 8.06 Mn |
| Apr 3, 2026 | 5.21 Mn |
| Jan 2, 2026 | -2.85 Mn |
| Sep 26, 2025 | 8.88 Mn |
| Jun 27, 2025 | -16.81 Mn |
| Mar 28, 2025 | -54.21 Mn |
| Dec 27, 2024 | -78.04 Mn |
| Sep 27, 2024 | 9.98 Mn |
| Jun 28, 2024 | 7.38 Mn |
| Mar 29, 2024 | -3.34 Mn |
| Dec 29, 2023 | 54.14 Mn |
| Sep 29, 2023 | 4.82 Mn |
| Jun 30, 2023 | 6.06 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 30, 2022 | 28.45 Mn |
| Sep 30, 2022 | 10.26 Mn |
| Jul 1, 2022 | 13.04 Mn |
| Apr 1, 2022 | 9.60 Mn |
| Dec 31, 2021 | 20.72 Mn |
| Oct 1, 2021 | 6.02 Mn |